APA (7th ed.) Citation

D, N., EV, Y., Y, W., T, A., & LE, Z. (2026). Noradrenaline reuptake inhibitors (NRIs) for attention deficit hyperactivity disorder (ADHD) in adults. The International journal of risk & safety in medicine, 9246479261461033. https://doi.org/10.1177/09246479261461033

Chicago Style (17th ed.) Citation

D, Nurkhametova, Yudina EV, Wei Y, Abakumova T, and Ziganshina LE. "Noradrenaline Reuptake Inhibitors (NRIs) for Attention Deficit Hyperactivity Disorder (ADHD) in Adults." The International Journal of Risk & Safety in Medicine 2026: 9246479261461033. https://doi.org/10.1177/09246479261461033.

MLA (9th ed.) Citation

D, Nurkhametova, et al. "Noradrenaline Reuptake Inhibitors (NRIs) for Attention Deficit Hyperactivity Disorder (ADHD) in Adults." The International Journal of Risk & Safety in Medicine, 2026, p. 9246479261461033, https://doi.org/10.1177/09246479261461033.